EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Diet and Gut Microbiota in Inflammatory Bowel Disease: A Clinical and Nutritional Perspective

Luisa Bertin iD, Sonia Facchin iD, Brigida Barberio, Daria Maniero iD, Greta Lorenzon iD, Francesco Cesaroni, Miriana Zanconato, Giulia Romanelli, Francesco Francini-Pesenti, Luca Busetto iD, Mara Cananzi, Paola Gaio und 5 weitere

Pharmaceuticals · 14.02.2026 · 19 (2) · 318

DOI: 10.3390/ph19020318 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 14.02.2026. Verfasst von Luisa Bertin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Oncology, Gastroenterology, University of Padua, 35128 Padova, Italy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 322 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel diseases, comprising Crohn’s disease and ulcerative colitis, represent chronic inflammatory disorders with rising global incidence, underscoring the pivotal role of modifiable environmental factors in disease pathogenesis. Diet and intestinal microbiota have emerged as critical bidirectional therapeutic targets through complex interactions with host immune responses. Epidemiological evidence demonstrates that healthy and high fiber diets reduce disease risk, while ultra-processed foods and inflammatory dietary patterns increase susceptibility. Therapeutic nutritional interventions, including exclusive enteral nutrition, the Crohn’s Disease Exclusion Diet combined with partial enteral nutrition, and the Mediterranean diet can induce and maintain clinical remission while promoting favorable microbiome modifications characterized by the enrichment of butyrate-producing taxa such as Faecalibacterium prausnitzii and Roseburia species, alongside a reduction in pathogenic Proteobacteria. Micronutrient deficiencies affect up to 78% of patients through malabsorption, chronic blood losses, dietary restrictions, and drug–nutrient interactions. Nutritional status significantly impacts surgical outcomes, with preoperative malnutrition and sarcopenia associated with increased postoperative complications, and it reciprocally influences biologic therapy response. Integration of personalized, microbiome-informed dietary strategies as complementary components of comprehensive treatment plans represents a promising therapeutic frontier, requiring multidisciplinary collaboration, rigorous clinical trials with standardized microbiome analyses, and precision nutrition algorithms accounting for disease phenotype, baseline microbial composition, and individual patient characteristics to optimize outcomes and improve quality of life.

Schlagwörter

Stichwörter der Autor:innen

CDCDEDIBDUCdietexclusive enteral nutritionmediterranean dietmicrobiome

Autor:innen und Institutionen

  • Department of Surgery, Oncology, Gastroenterology, University of Padua, 35128 Padova, Italy.
  • Gastroenterology Unit, Azienda Ospedale-Università Padova, 35128 Padova, Italy.
  • Dietetics and Clinical Nutrition Unit, Padova University Hospital, 35128 Padova, Italy.
  • Clinical Nutrition Unit, Department of Medicine, University of Padova, 35128 Padova, Italy.
  • Department of Medicine, University of Padova, 35128 Padova, Italy.
  • Unit of Pediatric Gastroenterology, Digestive Endoscopy, Hepatology and Care of the Child with Liver Transplantation, Department of Women's and Children's Health, University Hospital of Padova, 35128 Padova, Italy.

ORCID-Profile: Luisa Bertin, Sonia Facchin, Daria Maniero, Greta Lorenzon, Luca Busetto, Luca Bosa, Fabiana Zingone, Edoardo Vincenzo Savarino

Zitieren

APA

Bertin, L., Facchin, S., Barberio, B., Maniero, D., Lorenzon, G., Cesaroni, F., Zanconato, M., Romanelli, G., Francini-Pesenti, F., Busetto, L., Cananzi, M., Gaio, P., Bosa, L., Zingone, F., Gianolio, L., Damas, O. M., & Savarino, E. V. (2026). Diet and Gut Microbiota in Inflammatory Bowel Disease: A Clinical and Nutritional Perspective. Pharmaceuticals, 19(2), 318. https://doi.org/10.3390/ph19020318

Vancouver

Bertin L, Facchin S, Barberio B, Maniero D, Lorenzon G, Cesaroni F, et al. Diet and Gut Microbiota in Inflammatory Bowel Disease: A Clinical and Nutritional Perspective. Pharmaceuticals. 2026;19(2):318. doi:10.3390/ph19020318

BibTeX
@article{Bertin2026,
  author = {Bertin, Luisa and Facchin, Sonia and Barberio, Brigida and Maniero, Daria and Lorenzon, Greta and Cesaroni, Francesco and Zanconato, Miriana and Romanelli, Giulia and Francini-Pesenti, Francesco and Busetto, Luca and Cananzi, Mara and Gaio, Paola and Bosa, Luca and Zingone, Fabiana and Gianolio, Laura and Damas, Oriana M and Savarino, Edoardo Vincenzo},
  title = {Diet and Gut Microbiota in Inflammatory Bowel Disease: A Clinical and Nutritional Perspective},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {2},
  pages = {318},
  doi = {10.3390/ph19020318}
}
Kostenlos starten →